Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 5Cohance Lifesciences
02 12care4
03 9ANI Pharmaceuticals Inc
04 2Abbott Laboratories
05 5Actavis Inc
06 2Ajanta Pharma Limited
07 4Alphapharm PTY Ltd
08 9Apotex Inc
09 4Arrow Pharmaceuticals
10 1Aspire Lifesciences Pvt Ltd
11 3Avet Pharmaceuticals
12 10BGP Group of Companies
13 2BGP PHARMA ULC
14 5Bionpharma
15 3Chartwell Pharmaceuticals llc
16 2EG SpA
17 2EG Spa
18 2ENDO OPERATIONS
19 5Jazz Pharmaceuticals
20 2Medichem S.A
21 3NORVIUM BIOSCIENCE
22 1ORIFARM GROUP AS
23 1Oethmaan Biosims
24 2Pharmascience Inc.
25 1Sandoz B2B
26 2Smith & Kenner Pharmaceuticals
27 4Solvay Chemicals International S.A
28 3Sun Pharmaceutical Industries Limited
29 3Synthon Pharmaceuticals
30 5Teva Pharmaceutical Industries
31 2Torrent Pharmaceuticals Limited
32 6Upsher-Smith Laboratories
33 16Viatris
34 4WAGNER PHARMACEUTICALS PTY LTD
35 4Blank
01 4Antic-calc Tablet, Film Coated
02 12CAPSULE, EXTENDED RELEASE;ORAL
03 4Capsule
04 2FILM COATED PILL
05 3Film Coated Tablet
06 8Film-Coated Tablets
07 2Filmtable
08 4Fluvoxamine 100Mg 30 Joined' Oral Use
09 4Fluvoxamine 50Mg 30 Joined' Oral Use
10 1Pellets
11 4TAB
12 8TABLET
13 3TABLET; ORAL
14 48TABLET;ORAL
15 2Tabl
16 6Tablet
17 20tablet
01 40DISCN
02 3Generic
03 1Originator
04 8Prescription
05 20RX
06 63Blank
01 130 Dumirox 100Mg Film-Coated Tablets
02 130 Dumirox 50Mg Film-Coated Tablets
03 2APO-FLUVOXAMINE
04 4APO-Fluvoxamine
05 2DUMIROX
06 2Dumirox
07 2FEVARIN
08 2FLUVOXAMINE EG
09 51FLUVOXAMINE MALEATE
10 4FLUVOXAMINE-WGR
11 2Farin
12 3Faverin 100
13 2Faverin 50
14 6Fevarin
15 2Floxifral
16 2Floxifral Junior
17 2Fluvoxamine
18 1Fluvoxamine 100 Oethmaan
19 1Fluvoxamine Sandoz 100Mg 30 Tablets Efg
20 1Fluvoxamine Sandoz 50Mg 30 Tablets Rec Efg
21 1Fluvoxamine- Hexal
22 12LUVOX
23 2LUVOX CR
24 4Luvox
25 1Luvox 100
26 2MAVERAL
27 2Maveral
28 2Movox 100
29 2Movox 50
30 2PMS-FLUVOXAMINE
31 2TEVA-FLUVOXAMINE
32 10Blank
01 20Australia
02 8Canada
03 8India
04 16Italy
05 4Norway
06 4South Africa
07 6Spain
08 2Sweden
09 4Switzerland
10 63USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2007-12-20
Application Number : 21519
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-28
Application Number : 22033
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX CR
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 2008-02-28
Application Number : 22033
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET; ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 22235
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LUVOX
Dosage Form : TABLET;ORAL
Dosage Strength : 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1994-12-05
Application Number : 20243
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 25MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : FLUVOXAMINE MALEATE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2001-01-05
Application Number : 75887
Regulatory Info : DISCN
Registration Country : USA
